CompletedPhase 2NCT00990535
High Dose Somatostatin Analogues in Neuroendocrine Tumors
Studying Multiple endocrine neoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federico II University
- Principal Investigator
- Annamaria Colao, MD, PhDUniversity Federico II of Naples
- Intervention
- Octreotide-LAR(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2006 – 2008
Study locations (1)
- University Federico II of Naples, Naples, Italy
Collaborators
University of Perugia, Faculty of Medicine, Department of Internal Medicine · University of Genova · University Hospital, Udine, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00990535 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia
Additional recruiting or active studies for the same condition.